Congenital insensitivity to pain with anhidrosis (CIPA) is characterized by insensitivity to pain, anhidrosis, recurrent hyperpyrexia, mild mental retardation, and self-mutilating behavior. We report 2 brothers, aged 20 and 18 years, who suffered from phenotypes of CIPA. Both brothers had a branch site mutation in intron 7 (IVS7-33 T→A) of the neurotrophic tyrosine kinase receptor type 1 gene. The electrophysiological studies showed no significant abnormal findings in sensory evoked potentials, motor evoked potentials to transcranial magnetic stimulation, or heart rate variations; sympathetic skin responses were absent. Morphometric study of their sural nerve histopathology revealed normal myelinated fiber density, 8,082 fibers/mm2 and 5,637 fibers/mm2 (normal 6,141 ± 421); decreased unmyelinated fiber density, 2,537 fibers/mm2 and 2,211 fibers/mm2 (normal 28,578 ± 8,669); increased axon size, 4.41 ± 1.59 µm and 5.33 ± 1.48 µm (normal 3.73 ± 1.45), and increased axon diameter (A)/myelin thickness (M) ratio (A/M), 3.47 ± 1.42 and 2.70 ± 1.07 (normal 2.49 ± 0.93). Scatterplot analysis of the G ratio (axon diameter:fiber diameter) did not show consistent results in the relationship between axon size and myelin thickness. In conclusion, the neuropathy of our CIPA patients included a marked reduction of small myelinated and unmyelinated fibers and a relatively increased axon size. This is the first CIPA family encountered in Taiwan.

1.
Swanson AG: Congenital insensitivity to pain with anhidrosis. Arch Neurol 1963;8:299–306.
2.
Dyck PJ: Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons; in Dyck PJ, Tomas PK, Griffin JW, Low PA, Poduslo JF (eds): Peripheral Neuropathy. Philadelphia, Saunders, 1993, pp 1065–1093.
3.
Martin-Zanca D, Oskam R, Mitra G, Copeland T, Barbacid M: Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol 1989;9:24–33.
4.
Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF: The trk proto-oncogene product: A signal transducing receptor for nerve growth factor. Science 1991;252:554–558.
5.
Greco A, Villa R, Pierotti MA: Genomic organization of the human NTRK1 gene. Oncogene 1996;13:2463–2466.
6.
Indo Y, Mardy S, Tsuruta M, Karim MA, Matsuda I: Structure and organization of the human TRKA gene encoding a high affinity receptor for nerve growth factor. Jpn J Hum Genet 1997;42:343–351.
7.
Indo Y: Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): Mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Hum Mutat 2001;18:462–471.
8.
Indo Y, Tsuruta M, Hayashida Y, Karim MA, Ohta K, Kawano T, Mitsubuchi H, Tonoki H, Awaya Y, Matsuda I: Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet 1996;13:485–488.
9.
Goebel HH, Veit S, Dyck PJ: Confirmation of virtual unmyelinated fiber absence in hereditary sensory neuropathy type IV. J Neuropathol Exp Neurol 1980;39:670–675.
10.
Rafel E, Alberca R, Bautista J, Navarrete M, Lazo J: Congenital insensitivity to pain with anhidrosis. Muscle Nerve 1980;3:216–220.
11.
Matsuo M, Kurokawa T, Goya N, Ohta M: Congenital insensitivity to pain with anhidrosis in a 2-month-old boy. Neurology 1981;31:1190–1192.
12.
Itoh Y, Yagishita S, Nakajima S, Nakano T, Kawada H: Congenital insensitivity to pain with anhidrosis: Morphological and morphometrical studies on the skin and peripheral nerves. Neuropediatrics 1986;17:103–110.
13.
Rosemberg S, Marie SK, Kliemann S: Congenital insensitivity to pain with anhidrosis (hereditary sensory and autonomic neuropathy type IV). Pediatr Neurol 1994;11:50–56.
14.
Hilz MJ, Stemper B, Axelrod FB: Sympathetic skin response differentiates hereditary sensory autonomic neuropathies III and IV. Neurology 1999;52:1652–1657.
15.
Mardy S, Miura Y, Endo F, Matsuda I, Sztriha L, Frossard P, Moosa A, Ismail EA, Macaya A, Andria G, Toscano E, Gibson W, Graham GE, Indo Y: Congenital insensitivity to pain with anhidrosis: Novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor. Am J Hum Genet 1999;64:1570–1579.
16.
Lin KP, Chan MH, Wu ZA: Nerve conduction studies in healthy Chinese: Correlation with age, sex, height and skin temperature. Chin Med J (Taipei) 1993;52:293–297.
17.
Baba M, Watahiki Y, Matsunaga M, Takebe K: Sympathetic skin response in healthy man. Electromyogr Clin Neurophysiol 1988;28:277–283.
18.
Ewing DJ: Noninvasive evaluation of heart rate: The time domain; in Low PA (ed): Clinical Autonomic Disorders: Evaluation and Management. Boston, Little Brown, 1993, pp 297–314.
19.
American EEG Society: Guidelines on evoked potentials. J Clin Neurophysiol 1994;11:66–72.
20.
Liao KK, Chen JT, Lin KP, Chen CC, Kao KP, Wu ZA: Brain dysfunction explored by long latency reflex: A study of adrenomyeloneuropathy. Acta Neurol Scand 2001;104:105–109.
21.
Allison T, Goff WR, Williamson PD, VanGilder JC: On the neural origin of early components of the human somatosensory evoked potential; in Desmedt JE (ed): Clinical Uses of Cerebral, Brainstem and Spinal Somatosensory Evoked Potentials. Basel, Karger, 1980, pp 51–68.
22.
Thoenen H, Barde YA: Physiology of nerve growth factor. Physiol Rev 1980;60:1284–1335.
23.
Levi-Montalcini R: The nerve growth factor: Thirty-five years later. EMBO J 1987;6:1145–1154.
24.
Swanson AG, Buchan GC, Alvord EC Jr: Anatomic changes in congenital insensitivity to pain: Absence of small primary sensory neurons in ganglia, roots, and Lissauer’s tract. Arch Neurol 1965;12:12–18.
25.
Miura Y, Mardy S, Awaya Y, Nihei K, Endo F, Matsuda I, Indo Y: Mutations and polymorphism analysis of the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor in congenital insensitivity to pain with anhidrosis (CIPA) families. Hum Genet 2000;106:116–124.
26.
Vital A, Fontan D, Julien J, Talon P, Heron B, Routon MC, Ponsot G, Vital C: Congenital insensitivity to pain with anhidrosis. Report of two unrelated cases. J Peripher Nerv Syst 1998;3:125–132.
27.
Jacobs JM, Love S: Qualitative and quantitative morphology of human sural nerve at different ages. Brain 1985;108:897–924.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.